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ABSTRACT 
Sleep change is commonly reported in Alzheimer’s disease (AD) patients and their brain wave studies show 
decrease in dreaming and non-dreaming stages. Although sleep disturbance is generally considered as a consequence 
of AD, it might also be a risk factor of AD as new biological evidence shows. Leveraging National Sleep Research 
Resource (NSRR), we built a unique cohort of 83 cases and 331 controls with clinical variables and EEG signals. 
Supervised tensor factorization method was applied for this temporal dataset to extract discriminative sleep patterns. 
Among the 30 patterns extracted, we identified 5 significant patterns (4 patterns for AD likely and 1 pattern for 
normal ones) and their visual patterns provide interesting linkage to sleep with repeated wakefulness, insomnia, 
epileptic seizure, and etc. This study is preliminary but findings are interesting, which is a first step to provide 
quantifiable evidences to measure sleep as a risk factor of AD. 
 
 
INTRODUCTION 
Alzheimer’s disease (AD) has become a major public health concern because of its increasing prevalence, 
chronicity, caregiver burden, and high personal and financial costs of care. About 25% to 40% of AD patients suffer 
from disturbances of sleep, such as insomnia at night, rapid eye movement (REM) sleep behavior disorder, agitated 
behavior at sunset and excessive sleeping during the daytime [1]. In addition, sleep apnea syndrome is prevalent in 
AD patients [2], which is associated with APOE4 that is a well-known risk factor of AD [3].  Those sleep problems 
occur early on in the course of AD, consistent with the finding that brain regions involved in sleep are affected 
during the development of AD.  This fact implies that these sleep problems can be a preclinical marker for the 
development of AD [4]. A quantitative tool to measure such a sleep disturbance is electroencephalography (EEG), 
which is one of the most popular brain signals that records brain’s spontaneous electrical activity on different 
regions of scalp over a period of time. This signal usually transforms to multiple waves according to frequency 
domain (e.g., Alpha, Theta, Delta). EEG can quantify sleep patterns. In the normal young adult, sleep consists of 
five cycle stages:  
I. Stage 1 (5%):  a period of transition from wakefulness (Alpha wave, 8-10.5 Hz) to light sleep (Theta wave, 
4 - 8 Hz); 
II. Stage 2 (50%): light sleep with Theta wave (4 - 8 Hz); 
III. Stage 3 and Stage 4 (20%): slow-wave activity (SWA) or deep sleep with Delta wave (1 - 4 Hz); 
IV. Stage 5 (25%): REM sleep with a fast desynchronized EEG containing Alpha (8 - 10.5 Hz), Beta (15 - 30 
Hz), and Theta (4 - 8 Hz) waves [5]. 
 
With increasing age, sleep becomes “lighter” in that the percentage of Stage 1 increases and the percentage of Stage 
3 and 4 decreases. Patients with AD show an increased number and duration of awakenings [6,7], consequently EEG 
recordings show that percentage of Stage 1 increases and percentage of Stage 2 and SWA (Stage 3 and 4) decreases 
more than normal aging does. Another interesting EEG pattern of AD is that the amount of REM sleep decreases 
and this change is mostly seen in later stages of AD [7]. Also, EEG slowing is observed prominently in REM sleep 
(other than in the awake EEG) [8,9]. These findings are driven by researchers who have been visually compared 
EEG between normal elderly and AD patients with their human naked eyes [9]. Unfortunately, this ad-hoc approach 
is not scalable to large samples and have difficulty in exploring a large combination of patterns associated with 
temporal changes on frequency bands and brain regions across sleep cycles [6]. Lack of quantifiable measurement 
can be another issue, which might lead to inconsistency in judgement. Therefore, a computational method that 
directly learns sleep patterns from observational data becomes more important in discovering meaningful and 
generalizable latent patterns of sleep EEG.  
 
Dimensionality reduction is a widely-used method to discover such underlying latent space from high dimensional 
data. Particularly, linear models, such as principal component analysis, linear discriminant analysis, and nonnegative 
matrix factorization, represent the observed data as a weighted linear sum of latent dimensions and have been widely 
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applied in EEG analysis [10]. Nonnegative tensor factorization (NTF) is another powerful linear model, which 
decomposes high dimensional data (such as time-frequency representation of EEG from multiple samples) into 
linear sum of basis components (which are interpreted as patterns). NTF has been applied to several medical 
domains, such as phenotyping [11,12] from electronic medical records, temporal patterns from behavioral log [13], 
and event-related EEG [14–16]. To derive discriminative phenotypes or patterns with respect to certain clinical 
outcome of interest, an extension of NTF, so called supervised NTF, has been proposed and enforces the basis 
components to be discriminative to the clinical outcome of interest [12].  
 
In this work, we aim to discover temporal patterns from sleep EEG to differentiate AD from the control (non-AD), 
using supervised NTF. Previous studies on discovering AD patients’ EEG patterns use only event-related EEG (not 
focused on sleep EEG, which capture very different characteristic of brain functionality). Also, they are 
unsupervised approach within AD populations (not supervised approach discriminating AD case and non-demented 
control) [17,18]. We focus on the sleep EEG and integrate the supervision term explicitly in our objective function 
to derive discriminative temporal patterns as computational phenotypes. Main contributions of our study are: 
 
- Novelty: Our work is the first study to derive discriminative patterns of AD and classify AD using sleep 
EEG. 
- Secondary use of NSRR cohort: We leveraged a rich collection of de-identified electrophysiological signals 
and clinical data elements (large cohorts) from National Sleep Research Resource (NSRR), which 
empowers retrospective secondary analyses. 
- Consistency: Five representative patterns we derive were consistent with existing domain knowledge, 
which proves the validity of our method. We can further apply our validated methods to various 
applications.  
 
 
 
METHODS 
We developed a computational framework to discover sleep EEG patterns that would be discriminative to AD. This 
framework consists of three steps: i) patient matching; ii) EEG transformation; iii) tensor factorization (Figure 1). 
 
 
 
Figure 1. Overview of computational framework to discover discriminative patterns from Sleep EEG. This 
framework consists of three steps: i) patient matching; ii) EEG transformation; iii) tensor factorization. For each 
patient, the raw EEG signal was transformed into frequency-time representation using Fourier transform. The 
transformed EEG is a matrix format. We stacked all the individual matrices from each patient into a 3-order tensor.  
 
Datasets 
We leveraged two datasets in NSRR [19][20], which contains large collections of de-identified clinical data 
elements and electrophysiological signals from over 10 NIH-funded sleep cohort studies. Clinical data elements 
include demographic information (e.g., age, gender, race), anthropometric parameters (e.g., body mass index, 
height), physiologic measurements (e.g., diastolic/systolic blood pressure, heart rate), medical history (e.g., atrial 
fibrillation, cancer, depression), medications (e.g., antidepressant, acetylcholinesterase inhibitors for AD) and sleep 
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symptoms (e.g., excessive daytime sleepiness). Electrophysiological signals in the European Data Format (EDF) are 
the polysomnography recordings (overnight sleep), with various channels such as electroencephalogram (EEG) and 
electrocardiogram (ECG). The two datasets we used were the Sleep Heart Health Study (SHHS) [21] and MrOS 
Sleep Study (MrOS) [22][23][24], where SHHS contains a total of 5,804 adults aged 40 or older, and MrOS contains 
a total of 2,911 men aged 65 years or older. 
 
Since these two datasets are not specifically collected to study the relationship between sleep and AD, we performed 
retrospective analyses as a secondary use of these two datasets. To determine whether each patient has onset of AD 
we utilized a clinical variable on a specific medication, acetylcholinesterase inhibitors. Acetylcholinesterase 
inhibitors is widely used drug for AD. SHHS has a clinical variable asking if the patient has taken 
acetylcholinesterase inhibitors for AD within two weeks of the study visit. MrOS has three clinical data elements 
related to AD or AD medication use: (1) Has a doctor or other health care provider ever told you that you had 
dementia or AD? (2) Are you currently being treated for dementia or AD by a doctor? and (3) AD medication use. 
 
Cohort Selection using Propensity Score Matching 
Among 1,959 (MrOS) and 1,893 (SHHS) patients, we selected 331 controls normal (CN, non-AD) that match with 
83 case (AD) with around 4:1 ratio in terms of potential confounding risk factors to AD. Due to complex nature of 
AD’s neurodegeneration, many factors contribute to the disease. In order to focus on the relationship of AD and 
EEG signals, we need to reduce effects of other confounding variables that affect the incidence of AD, such as 
demographic background (e.g., age, gender, ethnicity) and potential risk factors (e.g., depression, hypertension, 
diabetes, cardiovascular disease, stroke). We utilized a statistical matching model called propensity score matching  
(PSM) [25], which matches estimators (i.e., confounders such as depression and hypertension) so that the 
distribution of EEG signals is independent of the outcome (i.e., AD), conditioned on the confounders [26]. The PSM 
algorithm finds the matched controls to the cases using two steps: i) computing propensity scores and ii) finding 
similar controls to each case using propensity scores. First, we obtained propensity scores as probability of AD 
computed from logistic regression, in which AD incidence is the binary label and confounders are predictors. Then 
we used Radius matching to find maximum n controls that fall within a predefined radius r (in terms of similarity of 
propensity scores). We conducted a line search to find the best combination of n and r that lead to biggest sample 
size within a tolerable bias.  
 
EEG Frequency Bands Representation 
We derived time-frequency representation from the raw EEG signals. EEG signals have various behaviors in 
different frequency bands, and the characteristics of different frequency bands are reported in previous work [27–
29]. For example, previous studies demonstrated that spectral power is an important feature for sleep stage research 
[30], such as: the power of lower frequencies of EEG becomes stronger with the increasing depth of sleep; the EEG 
signal of Stage 1 has more power between 2-7 Hz; Stage 2 can be characterized by the presence of sleep spindles 
band (12-15 Hz), and SWA is defined when there are low frequency (less than 2 Hz) waves [31]. 
 
We first divided the entire sleep EEG records into non-overlap 30-second epochs during 8 hours (i.e., 8 hours / 30 
seconds = 960 epochs). EGG signals after the 8 hours were truncated. After separating EEG time dimension into 960 
epochs, we separated the EEG values into several waves depending on its frequency bandwidths using power 
spectral analysis. The most standard frequency bands include Delta wave, Theta wave, Alpha wave (Table 1). Fast 
Fourier transform (FFT) is a direct and commonly used spectral estimation method for the EEG frequency analysis 
[28]. The discrete Fourier transform (DFT) is an efficient numerical algorithm to perform Fourier transform in many 
practical applications. Let us denote N is the number of EEG values in one epoch and 𝑥" as a single EEG value in 
one epoch. The DFT of a sequence of N values {xn}:= x0,x1,…,xN-1 is defined as： 𝑋$ = 1𝑁(𝑥" ∙ 𝑒+(-."$/0)20"34  
 
where {Xk}: = X0,X1,…,XN-1 is a transformed sequence of {xn} for 𝑘 = 0, . . . , 𝑛 − 1, and e is the Euler's number. The 
power spectrum is then obtained with 𝑃$ = 	‖𝑋$‖-. 
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The 𝑃$values for 𝑘 = 0, . . . , 𝑛 − 1 are then separated according to the 12 frequency bands (Table 1). For example, 𝑃$  
values lying in every ¼ to ⅛ seconds (4 - 8 Hz) correspond to Theta wave. For each frequency band, we summed all 
the 𝑃$  values and used it as an amplitude value. So, in total 12 frequency amplitude values are generated per every 
epoch.  
 
Table 1. Extracted EEG frequency bands.  
Name Hz Name Hz 
Slow-Oscillations (SO) [0.5, 1.5] Sigma [12.0, 15.0] 
Slow-wave activity (SWA) [0.5, 5.5] Slow Sigma [12.0, 13.5] 
Delta [1.0, 4.0] Fast Sigma [13.5, 15.0] 
Theta [4.0, 8.0] Beta1 [15.0, 20.0] 
Alpha [8.0, 10.5] Beta2 [20.0, 30.0] 
Spindle [10.5, 14.5] Gamma [30.0, 60.0] 
 
Discovering Biomarkers using Tensor Factorization 
Using the EEG time-frequency representation of each patient, we constructed an observed tensor and extracted 
discriminative temporal patterns by applying supervised NTF to the observed tensor. 
 
Construct Tensor. To derive patterns from time-frequency representation of EEG, we represent each patient’s signal 
amplitude as a matrix (12 frequency bands × 960 time slots), see Figure 2. We applied log2-transform to the 
amplitude to make the distribution follow normal distributions and facilitate stable tensor factorization. We stacked 
those matrices into a third-order tensor 𝑂 with a shape of (83 AD + 331 CN) patients ×12 frequency bands × 960 
time slots (Tensor is a generalization of matrix. Order of a tensor is the number of dimensions. A first-order tensor is 
a vector, a second-order tensor is a matrix, and tensors of order three or higher are called high-order tensors). 
 
 
 
 
Figure 2. EEG time-frequency representation of all patients forms a tensor. AD= Alzheimer’s disease, CN= 
Control.  
 
Regularized Nonnegative Tensor Factorization. The most widely used tensor decomposition is CP method [32]. A 
third-order tensor 𝑂with shape of 𝐼 × 𝐽 × 𝐾 is rank-one if it is an outer product of three vectors 𝑎, 𝑏, 𝑐, i.e., 𝑂 = 𝑎 ∘𝑏 ∘ 𝑐 where ∘ means the vector outer product. 𝑂2F$, the element at (𝑖, 𝑗, 𝑘) in the tensor 𝑂, is computed as product of 
elements in the vector, i.e., 𝑂2F$ = 𝑎2𝑏F𝑐$. Tensor factorization (TF) is a dimensionality reduction approach that 
represents the original tensor as latent dimensions. The CP model approximates the original observed tensor 𝑂 as a 
linear combination of rank-one tensors [32]; that is, a third-order tensor 𝑂 is decomposed as minimizing difference 
between observed tensor and approximated tensor as 𝐿 = ||	𝑂 − ∑ 𝑎L ∘ 𝑏L 	∘ 𝑐LML31 ||2   
where a positive integer 𝑅is the rank, 𝑎L, 𝑏L, 𝑐Lare r-th column vectors in matrix 𝐴,𝐵, 𝐶 with shape of 𝐼 × 𝑅, 𝐽 ×𝑅,𝐾 × 𝑅, respectively. Here, 𝐴, 𝐵, 𝐶 are called as factor matrices. When tensor 𝑂 contains non-negative data (such 
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as amplitude, intensity or counts), we set non-negative constraints 𝐴,𝐵, 𝐶	 ≥ 0for interpretability of latent 
dimensions, which is so called nonnegative tensor factorization (NTF).  Since our objective is to derive 
discriminative patterns, we used supervised version of TF, which adds a supervised regularizer that encourages the 
patterns to be separated according to AD vs CN [12]. The supervised TF adds logistic regression regularizer as 𝐿 − 𝜇 ⋅𝑙𝑜𝑔 𝑃(𝐴, 𝑦|𝜃) = 𝐿 − 𝜇 ⋅ 1
1 + 𝑒𝑥𝑝(−𝑦 ⋅ 𝜃𝐴) 
where 𝜇 is a weight parameter to balance the tensor error and the loss on regularizer, 𝜃is parameter for logistic 
regression, and 𝑦is label (𝑦 = 1 if AD; -1 CN). To further enhance interpretability via compact patterns, we also 
added 𝑙1norm regularizer to the factor matrix. The 𝑙1 regularizer shrinks the less important coefficients to zero, as 
improving interpretability of model: 𝐿	 + 𝜆 ⋅ (||𝐴||1	 + 	 ||𝐵||1	 + ||𝐶||1	) 
where 𝜆is a weight parameter to balance the tensor error and the 𝑙1norm loss. Therefore, our final objective function 
is adding both of regularizers:  𝐿	 − 𝜇 ⋅𝑙𝑜𝑔 𝑃(𝐴, 𝑦|𝜃) + 𝜆 ⋅ (||𝐴||1	 + 	 ||𝐵||1	 + ||𝐶||1	).  
 
Discover Patterns using NTF. We applied this regularized NTF to our EEG dataset. We let factor matrix A, B, and 
C represent patients (AD + CN), frequency bands, and time slots, respectively. The R latent dimensions in factor 
matrices A, B, and C represent temporal patterns of EEG. Each EEG pattern consists of a set of frequency bands and 
a set of time slots. Individual frequency band or time slot contributes to the pattern with different extent of 
membership, and the amount of contribution is stored in columns of B and C.  Likewise, individual patients have 
characteristics of the R patterns with different extent of membership. That is, the column vector of 𝐵 defines how 
much the frequency bands are involved in each pattern, and the column vector of 𝐶 defines how much the time slots 
are involved in each pattern. The row vector of 𝐴 defines how much patients participate (or have membership) in the 
characteristic of each pattern.   
 
EXPERIMENTS AND RESULTS 
 
Propensity Score Matching 
To create our training cohort for regularized NTF, we obtained controls for the cases from our data sources (MrOS, 
SHHS). We used propensity score matching to reduce the effect of age, race, common risk factors (hypertension, 
depression, stroke, diabetes) while trying to keep as much cases as possible. After matching, we lost a few cases in 
order to reduce the bias. We ended up with 83 cases and 331 controls at a roughly 1:4 ratio. Tables 2a and 2b 
summarize the statistics on features before and after the matching. 
 
Table 2a: Statistics of MrOS dataset before and after matching 
Feature 
Original Dataset PS Matched Dataset 
AD cohort Control cohort  AD cohort Control cohort 
Number of Patients  86 2,397 55 203 
Age 80.14±5.36 77.6±5.53 78.87±5.57 78.21±5.59 
Race   86% 88.6% 94.5% 98.0% 
Hypertension 50% 81.6% 67.3% 78.8% 
Depression 5.8% 3.7% 3.6% 2.0% 
Stoke 10.5% 6.3% 3.6% 1.0% 
Diabetes 14.0% 18.7% 14.5% 6.9% 
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Table 2b: Statistics of SHHS dataset before and after matching 
Feature 
Original Dataset PS Matched Dataset 
AD cohort Control cohort  AD cohort Control cohort 
Number of Patients 33 1,860 28 126 
Age 79.6±6.9 73.5±7.83 78.9±7.1 76.5±6.67 
Gender - Female 48.5% 53.5% 50% 42.9% 
Race - Caucasian  87.9% 88.9% 89.3% 98.4% 
Race - African American 9.1% 8.8% 7.1% 1.6% 
Cardiovascular Disease 39.4% 29.2% 39.3% 23.8% 
Hypertension 51.5% 95.6% 60.7% 96.8% 
Stoke 6.1% 4.5% 0% 1.6% 
 
 
Discovering Biomarker using Tensor Factorization 
We implemented the regularized NTF using Pytorch 11.4 with adaptive momentum estimation (ADAM) for 
optimization. We set the maximum number of iterations as 1,000. The running time was less than 15 secs with 3 
parallel GPUs. We added dropout to logistic regression coefficients for robustness. After extensive parameter 
tuning, we set dropout rate=0.5, R=30, 𝜇 = 0.1, and 𝜆 = 0.05. 
 
Evaluating NTF methods. We computed discriminative power, sparsity, overlap of patterns that are derived from 
the NTF methods. We measured the discrimination by the area under the receiver operating characteristic curve 
(AUC) to classify AD and control. We measured compactness by sparsity and overlap of the temporal patterns. High 
sparsity means a few frequency bands or time period dominantly characterize each pattern whereas the other bands 
or time period are negligible, making interpretation of the patterns easy. The sparsity was computed as an averaged 
Gini index of involvement values in each pattern (i.e., the column vectors of B and C) [33]. The overlap measures 
the degree of overlapping between all pattern pairs [12]. Patterns with less overlap are more distinctly identified. 
The overlap is computed as an averaged cosine similarity between all pair of column vectors of B and C. We also 
computed mean squared error (MSE) to evaluate how closely the derived patterns reflect the observed original data. 
We computed mean and standard deviation after ten repeated trials. We compared the discriminative power and 
compactness with different settings of regularizers: 
 
● NTF: Basic NTF model without any regulariziers (𝜇 = 0, 𝜆 = 0) 
● NTF + logit: NTF with supervised regularizer based on logistic regression likelihood (𝜇 = 0.1, 𝜆 = 0) 
● NTF +𝑙1norm: NTF with 𝑙1norm (𝜇 = 0, 𝜆 = 0.05) 
● NTF +𝑙1norm+logit: NTF with 𝑙1norm and logistic regression likelihood (𝜇 = 0.1, 𝜆 = 0.05) 
 
Table 3 summarizes interested measurements. We found that NTF with 𝑙1norm and supervised term outperforms 
other baselines in terms of discriminative power and compactness. The NTF +𝑙1norm+logit showed the highest 
AUC, sparsity, and lowest overlap (Table 3). The 𝑙1norm regularizer improved compactness (i.e., increased sparsity 
and decreased overlap). The supervised regularizer also improved discriminative power (i.e., increased AUC).  
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Table 3. Discrimination and compactness comparison. We computed average and standard deviation after 10 
repeated trials. The number of phenotypes R=30.  
Methods AUC Sparsity Overlap MSE 
NTF  
(𝜇 = 0, 𝜆 = 0)  0.6716 (0.0321)  0.1799 (0.0078)  0.8936 (0.0094) 0.3061 (0.0038) 
NTF + 𝑙1norm  
(𝜇 = 0, 𝜆 = 0.05)  0.6684 (0.0385) 0.1821 (0.0105) 0.8914 (0.0111) 0.3068 (0.0023) 
NTF + logit  
(𝜇 = 0.1, 𝜆 = 0) 0.6743 (0.0328) 0.1788 (0.0069) 0.8956 (0.0081) 0.3076 (0.0034) 
NTF +𝑙1norm+logit 
(𝜇 = 0.1, 𝜆 = 0.05) 0.6852 (0.0259)  0.1822 (0.0066) 0.8913 (0.0075)  0.3079 (0.0025) 
 
Evaluating Individual Patterns. We presented patterns that an NTF +𝑙1norm+logit model derives (with 
AUC=0.6981). After deriving R=30 patterns, we learned a logistic regression model using the R=30 patterns as 
predictors and selected patterns that separate AD and CN with statistical significance (Table 4: Coefficient). Five 
patterns showing p-value < 0.05 were: Pattern 2 for CN and Patterns 4, 18, 28, and 30 for AD. That is, Patterns 4, 
18, 28, and 30 were positively related to AD whereas Pattern 2 was negatively related to AD. To verify this 
relationship, we reported the number of patients from AD and CN according to the extent of involving to each 
pattern, the membership values (Table 4: Membership distribution). We found that in AD patterns (4, 18, 28, and 
30) the ratio of AD patients to CN increases as the membership value increases. In contrast, in CN pattern 2 the ratio 
of AD patients to CN decreases as the membership value increases. These findings are consistent with the logistic 
regression results in which AD patients are more likely to have larger values on the Patterns 4, 18, 28, and 30; and to 
have smaller values on the Pattern 2. Note that we initially made cohort with ratio of AD:CN=1:4, thus the number 
of CN was always larger than the number of AD across all membership values.   
 
We visualized the five representative patterns (Table 4: Visualization). We represented each pattern using heatmap, 
according to the membership values of frequency bands or time slots. Frequency bands or time slots that dominantly 
characterize the pattern showed high values (bright yellow), whereas frequency bands or time slots that are less 
involved in the pattern showed low values (dark purple). Slow oscillation, slow wave activity, and spindle were 
overlapped with Delta and Sigma waves, so we denoted them separately where each band belongs to. 
 
Patterns can be interpreted in details as follows: 
- Pattern 2 - Healthy normal sleep. Pattern 2 was more prevalent to non-AD group. Pattern 2 forms a slow 
oscillation, slow wave activity and spindle, which none of AD EEG patterns have. Pattern 2 is consistent 
with the existing known fact that AD patient rarely forms spindle in Sigma wave (12 - 15 Hz) [34].  
- Pattern 4 and 18 - Epileptic seizure during sleep. Pattern 4 refers to Delta and Theta wave (0.5 Hz - 8 Hz) 
with slow oscillation and slow wave activity and also Gamma wave (30 Hz ~). This activity occurs during 
at the beginning and the end of sleep. Similarly, Pattern 18 refers to Theta wave (4 - 8 Hz) with Gamma 
wave (30 Hz ~) during the middle of sleep (4 - 7 hour). Because Gamma wave are not usually seen during 
sleep, we hypothesized that this combination of slow wave and high frequency wave is due to epilepsy, 
which is very common in AD and also main cause of AD [35]. A Gamma wave increase is found in 
epileptic patients, probably reflecting both cortical excitation and perceptual distortions such as deja vu 
phenomenon frequently observed in epilepsy [36]. During an epileptic seizure the EEG are mainly sharp 
waves and spikes that may also appear as spike-wave complexes in combination with the slow waves [36].   
- Pattern 28 - drowsy sleep. Pattern 28 was focused on Theta wave 4-8 Hz and Alpha 8-10.5 Hz waves 
several times throughout the 8 hours of sleep. This pattern is consistent with typical AD patient’s sleep 
pattern. It is known that AD patients usually wake up several times during nighttime [37]. As a result, the 
percentage of wakefulness and Stage 1 increases, which refer to the transition of the brain from Alpha 
waves (8-10.5 Hz) to Theta waves (4-8 Hz).  
- Pattern 30 - Insomnia. Pattern 30 has very strong signals on Beta and Gamma waves (15 Hz ~) during the 
first one hour and 5 - 8 hour of sleep. This sleep EEG pattern is accordant with that of insomnia patients, in 
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which Beta and Gamma activity usually increase [38]. Insomnia is one of common comorbidities of AD 
patients [1]. 
 
Table 4. Summary of representative five patterns. Logistic regression coefficient and p-value to classify AD from 
CN. Membership values distribution of AD and CN, and visualization of each pattern. SO= slow oscillation, 
SWA=slow wave activity. Range of membership values varies according to pattern. SO, SWA, and spindle were 
presented separately due to overlap.  
 
EEG 
pattern 
Coefficient 
(p-value) 
Membership distribution Visualization  
(Dominant frequency bands and time period) 
2 
(CN) 
-2.7164 
(0.034) 
 
 
SO, SWA                Spindle 
 
4 
(AD) 
1.8200 
(0.013) 
 
SO, SWA 
 
18 
(AD) 
1.4873 
(0.034) 
 
 
 
 
28 
(AD) 
2.4115 
(0.028) 
 
 
 
30 
(AD) 
2.1408 
(0.013) 
 
 
 
 
 
LIMITATION AND CONCLUSION 
Data collected in National Sleep Research Resource (NSRR) was meant for study sleeping. Although many clinical 
variables are collected, they are mostly focused on sleep but not specific to the AD population. Based on the 
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populational AD occurrence rate (at different ages), we believe there are more eligible patients for the study but it is 
hard to confirm. So, we end up with a relatively small population but results are still very interesting as we identified 
several distinctive patterns that are significantly associated with AD. These results still need further verification and 
biological explanation. Another limitation is related to the onset time of AD. 
 
In this study, we aimed to derive sleep patterns of AD patients using EEG signals. From National Sleep Research 
Resource, we built a unique cohort of 83 cases and 331 controls with clinical variables and EEG signals. We used a 
regularized nonnegative tensor factorization that can derive discriminative patterns. Among the 30 patterns 
extracted, we identified five significant patterns with p <0.05:  Health normal sleep with spindle; epileptic seizure 
during sleep; drowsy sleep with repeated wakefulness; and insomnia. This study is preliminary but finding are 
interesting, which is a first step to provide quantifiable evidences to measure sleep as a risk factor of AD. 
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